RB1
Retinoblastoma-associated protein
Also known as: OSRC, PPP1R130, RB, RB_HUMAN
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- P06400
- Gene
- RB1
- Ensembl
- ENSG00000139687
- Chromosome
- 13
- Canonical length
- 928 aa
- Protein class
- Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins
- Subcellular location
- Nucleoplasm
OverviewNCBI Gene
The protein encoded by this gene is a negative regulator of the cell cycle and was the first tumor suppressor gene found. The encoded protein also stabilizes constitutive heterochromatin to maintain the overall chromatin structure. The active, hypophosphorylated form of the protein binds transcription factor E2F1. Defects in this gene are a cause of childhood cancer retinoblastoma (RB), bladder cancer, and osteogenic sarcoma. [provided by RefSeq, Jul 2008]
Canonical amino-acid sequenceUniProt
928 residues, UniProt reviewed canonical sequence.
>P06400|RB1
1 MPPKTPRKTA ATAAAAAAEP PAPPPPPPPE EDPEQDSGPE DLPLVRLEFE ETEEPDFTAL
61 CQKLKIPDHV RERAWLTWEK VSSVDGVLGG YIQKKKELWG ICIFIAAVDL DEMSFTFTEL
121 QKNIEISVHK FFNLLKEIDT STKVDNAMSR LLKKYDVLFA LFSKLERTCE LIYLTQPSSS
181 ISTEINSALV LKVSWITFLL AKGEVLQMED DLVISFQLML CVLDYFIKLS PPMLLKEPYK
241 TAVIPINGSP RTPRRGQNRS ARIAKQLEND TRIIEVLCKE HECNIDEVKN VYFKNFIPFM
301 NSLGLVTSNG LPEVENLSKR YEEIYLKNKD LDARLFLDHD KTLQTDSIDS FETQRTPRKS
361 NLDEEVNVIP PHTPVRTVMN TIQQLMMILN SASDQPSENL ISYFNNCTVN PKESILKRVK
421 DIGYIFKEKF AKAVGQGCVE IGSQRYKLGV RLYYRVMESM LKSEEERLSI QNFSKLLNDN
481 IFHMSLLACA LEVVMATYSR STSQNLDSGT DLSFPWILNV LNLKAFDFYK VIESFIKAEG
541 NLTREMIKHL ERCEHRIMES LAWLSDSPLF DLIKQSKDRE GPTDHLESAC PLNLPLQNNH
601 TAADMYLSPV RSPKKKGSTT RVNSTANAET QATSAFQTQK PLKSTSLSLF YKKVYRLAYL
661 RLNTLCERLL SEHPELEHII WTLFQHTLQN EYELMRDRHL DQIMMCSMYG ICKVKNIDLK
721 FKIIVTAYKD LPHAVQETFK RVLIKEEEYD SIIVFYNSVF MQRLKTNILQ YASTRPPTLS
781 PIPHIPRSPY KFPSSPLRIP GGNIYISPLK SPYKISEGLP TPTKMTPRSR ILVSIGESFG
841 TSEKFQKINQ MVCNSDRVLK RSAEGSNPPK PLKKLRFDIE GSDEADGSKH LPGESKFQQK
901 LAEMTSTRTR MQKQKMNDSM DTSNKEEKLocalizationUniProt · AlphaFold · HPA
Whether an antibody against RB1 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.36
- Highest tissue expression
- 32 nTPM
Expression across tissuesHPA
Tissue
- thymus: 32 nTPM
- lymph node: 29 nTPM
- tonsil: 28 nTPM
- placenta: 23 nTPM
- spleen: 23 nTPM
- skin: 22 nTPM
Single-cell type
- melanocytes: 564 nCPM
- neutrophils: 543 nCPM
- microglia: 422 nCPM
- b-cells: 418 nCPM
- macrophages: 406 nCPM
- thymocytes: 379 nCPM
Immune cell
- memory B-cell: 30 nTPM
- naive B-cell: 30 nTPM
- basophil: 24 nTPM
- non-classical monocyte: 21 nTPM
- neutrophil: 21 nTPM
- intermediate monocyte: 20 nTPM
Brain region
- white matter: 35 nTPM
- medulla oblongata: 34 nTPM
- cerebellum: 29 nTPM
- spinal cord: 29 nTPM
- hypothalamus: 28 nTPM
- choroid plexus: 27 nTPM
DiseaseUniProt · ClinVar · IEDB · PubMed
Four sources answering four different questions about RB1.
Disease | AllUniProt
Conditions RB1 is implicated in, by any mechanism.
- Childhood cancer retinoblastoma (RB) MIM:180200
- Bladder cancer (BLC) MIM:109800
- Osteogenic sarcoma (OSRC) MIM:259500
Disease | GeneticClinVar
953 pathogenic / likely-pathogenic of 4,564 ClinVar records.
Conditions with pathogenic or likely-pathogenic variants.
- Retinoblastoma
- Hereditary cancer-predisposing syndrome
- Hereditary retinoblastoma
- Malignant tumor of urinary bladder
- Neoplasm
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.13
- gnomAD pLI
- 1
- gnomAD missense Z
- 2.67
- DepMap mean gene effect
- 0.24
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 4% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- aortic valve morphogenesis
- cell differentiation
- cell division
- cell morphogenesis involved in neuron differentiation
- cellular response to insulin stimulus
- cellular response to xenobiotic stimulus
- chondrocyte differentiation
- chromatin remodeling
- chromosome organization
- digestive tract development
- enucleate erythrocyte differentiation
- epithelial cell proliferation
- G1/S transition of mitotic cell cycle
- glial cell apoptotic process
- glial cell proliferation
- hepatocyte apoptotic process
- heterochromatin formation
- maintenance of mitotic sister chromatid cohesion
- myoblast differentiation
- negative regulation of apoptotic signaling pathway
- negative regulation of cell cycle
- negative regulation of cell growth
- negative regulation of cold-induced thermogenesis
- negative regulation of DNA-templated transcription
- negative regulation of epithelial cell proliferation
- negative regulation of G1/S transition of mitotic cell cycle
- negative regulation of gene expression
- negative regulation of glial cell proliferation
- negative regulation of hepatocyte apoptotic process
- negative regulation of inflammatory response
- negative regulation of myofibroblast differentiation
- negative regulation of protein kinase activity
- negative regulation of smoothened signaling pathway
- negative regulation of transcription by RNA polymerase II
- neuron apoptotic process
- neuron maturation
- neuron projection development
- positive regulation of collagen fibril organization
- positive regulation of extracellular matrix organization
- positive regulation of macrophage differentiation
- positive regulation of mitotic metaphase/anaphase transition
- positive regulation of transcription by RNA polymerase II
- positive regulation of transcription regulatory region DNA binding
- protein localization to chromosome, centromeric region
- Ras protein signal transduction
- regulation of cell cycle
- regulation of DNA-templated transcription
- regulation of lipid kinase activity
- regulation of mitotic cell cycle
- sister chromatid biorientation
- skeletal muscle cell differentiation
- smoothened signaling pathway
- spermatogenesis
- striated muscle cell differentiation
- tissue homeostasis
- transcription by RNA polymerase II
Molecular functions
- disordered domain specific binding
- DNA-binding transcription factor binding
- identical protein binding
- importin-alpha family protein binding
- kinase binding
- molecular adaptor activity
- phosphoprotein binding
- RNA polymerase II transcription regulatory region sequence-specific DNA binding
- RNA polymerase II-specific DNA-binding transcription factor binding
- transcription corepressor activity
- ubiquitin protein ligase binding
Cellular components
Protein domainsUniProt · Pfam · InterPro
- Retinoblastoma-associated protein, B-box
- Retinoblastoma-associated protein, A-box
- Cyclin-like domain
- Retinoblastoma-associated protein, C-terminal
- Retinoblastoma-associated protein, N-terminal
- Retinoblastoma protein family
- Cyclin-like superfamily
- Retinoblastoma-associated protein B domain
- Retinoblastoma-associated protein A domain
- Rb C-terminal domain
- Domain of unknown function (DUF3452)
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of RB1 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads RB1 as an antibody target. Whether an autoantibody or antibody against RB1 could matter depends on whether native RB1 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
RB1 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label RB1 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...